コンテンツへスキップ
Merck
  • Decreased bone marrow stromal cells activity involves in unilateral anterior crossbite-induced early subchondral bone loss of temporomandibular joints.

Decreased bone marrow stromal cells activity involves in unilateral anterior crossbite-induced early subchondral bone loss of temporomandibular joints.

Archives of oral biology (2014-06-16)
Ting Yang, Jing Zhang, Yukun Cao, Mian Zhang, Lei Jing, Kai Jiao, Shibin Yu, Meiqing Wang
要旨

Subchondral bone loss in mandibular condyles was reported to be induced by experimentally created unilateral anterior crossbite (UAC) which altered the occlusal load distribution and hereafter the temporomandibular joint (TMJ) remodelling process. However, the initial cellular responses are poorly understood. In the present study, changes in osteoblast and osteoclast activities in TMJ subchondral bone were investigated using the rats treated with UAC. Forty rats were randomly divided into UAC and control groups, and sampled at 2 weeks after the operation. Subchondral bone loss was evaluated by micro-CT. Osteoclast and osteoblast activities were analyzed by real-time PCR. The osteoblast differentiation of the locally isolated BMSCs from TMJ subchondral bone was assessed by Alizarin red staining. The migration of BMSCs was detected by transwell assays. Compared with the age-matched controls, TMJ subchondral bone loss was observed in the UAC-treated rats (p<0.05). The osteoblast activity evaluated by real-time PCR and osteoblast number revealed by immunohistochemical staining were reduced in the TMJ subchondral bone of UAC rats (p<0.05), and the capability of proliferation, migration and osteoblast differentiation were all decreased in the locally isolated BMSCs from the UAC group (p<0.05). The present data demonstrated an involvement of reduced BMSCs activity in the initiation of the mandibular subchondral bone loss at the early stage of installation of the aberrant prostheses.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
デキサメタゾン, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
3-イソブチル-1-メチルキサンチン, ≥99% (HPLC), powder
Sigma-Aldrich
L-アスコルビン酸, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L-アスコルビン酸, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
ヨウ化プロピジウム, ≥94.0% (HPLC)
Sigma-Aldrich
3-イソブチル-1-メチルキサンチン, BioUltra, ≥99%
Sigma-Aldrich
L-アスコルビン酸, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
デキサメタゾン, ≥98% (HPLC), powder
Sigma-Aldrich
L-アスコルビン酸, reagent grade, crystalline
USP
アスコルビン酸, United States Pharmacopeia (USP) Reference Standard
Supelco
L-アスコルビン酸, analytical standard
Sigma-Aldrich
L-アスコルビン酸, reagent grade
Sigma-Aldrich
L-アスコルビン酸, meets USP testing specifications
Sigma-Aldrich
デキサメタゾン, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
L-アスコルビン酸, FCC, FG
Sigma-Aldrich
L-アスコルビン酸, 99%
Sigma-Aldrich
L-アスコルビン酸, BioUltra, ≥99.5% (RT)
USP
デキサメタゾン, United States Pharmacopeia (USP) Reference Standard
Supelco
アスコルビン酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-アスコルビン酸, ACS reagent, ≥99%
Sigma-Aldrich
デキサメタゾン, meets USP testing specifications
Sigma-Aldrich
ヨウ化プロピジウム 溶液
Supelco
デキサメタゾン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe, ≥97% (HPLC)
Sigma-Aldrich
L-アスコルビン酸, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Sigma-Aldrich
ヨウ化プロピジウム, ≥94% (HPLC)
Sigma-Aldrich
L-アスコルビン酸, JIS special grade, ≥99.0%
アスコルビン酸, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
L-アスコルビン酸, puriss. p.a., ≥99.0% (RT)
Sigma-Aldrich
L-アスコルビン酸, tested according to Ph. Eur.